Coloplast: Great Quality And Growth But Priced To Perfection [Seeking Alpha]
COLOPLAST AS SP/ADR (CLPBY)
NASDAQ:AMEX Investor Relations:
coloplast.com/investor-relations
Company Research
Source: Seeking Alpha
The company has a stable business model and benefits from demographic trends and expanding healthcare coverage. Coloplast has faced margin pressure but expects cost developments to improve in the next fiscal year. The company has also announced its Strive 25 strategy for long-term growth. The stock is priced to perfection at 37x EPS, and we see no attractive risk/reward. We present our note on Coloplast ( OTCPK:CLPBY OTCPK:CLPBF ), a leading global supplier of intimate healthcare products, with a Hold rating. We are drawn by Coloplast's strong product portfolio, high market share, and customer stickiness, but we find the stock fully valued. We will provide a description of the firm, analyze its business model and product portfolio, value the company, and discuss risks to our rating. Introduction to Coloplast Coloplast is a Danish multinational medical device company that develops, manufactures, and markets products and services for people with very personal and private medi
Show less
Read more
Impact Snapshot
Event Time:
CLPBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLPBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLPBY alerts
High impacting COLOPLAST AS SP/ADR news events
Weekly update
A roundup of the hottest topics
CLPBY
News
- Skin Barrier Market to increase at a 3.8% CAGR with a valuation of US$ 540.9 million by 2034: Fact MR Report [Yahoo! Finance]Yahoo! Finance
- Medical-Fish-Skin Company Kerecis Receives Export Award from the President of Iceland [Yahoo! Finance]Yahoo! Finance
- Coloplast A/S - Interim Financial Report, Q1 2023/24 [Yahoo! Finance]Yahoo! Finance
- Coloplast launches Peristeen® Light for people with bowel disorders [Yahoo! Finance]Yahoo! Finance
- Coloplast launches Biatain® Silicone Fit for pressure injury prevention and wound management in the US [Yahoo! Finance]Yahoo! Finance